X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (45) 45
humans (44) 44
oncology (44) 44
female (38) 38
aged (35) 35
middle aged (32) 32
chemotherapy (31) 31
breast cancer (29) 29
adult (26) 26
treatment outcome (22) 22
aged, 80 and over (19) 19
breast neoplasms - drug therapy (19) 19
survival (19) 19
cancer (18) 18
breast neoplasms - pathology (16) 16
male (16) 16
care and treatment (14) 14
metastasis (14) 14
therapy (14) 14
antineoplastic combined chemotherapy protocols - therapeutic use (13) 13
analysis (12) 12
disease-free survival (12) 12
patients (12) 12
retrospective studies (12) 12
trastuzumab (11) 11
hematology, oncology and palliative medicine (10) 10
metastatic breast cancer (10) 10
cancer patients (9) 9
cancer therapies (9) 9
combination (9) 9
neoplasm metastasis (9) 9
breast neoplasms - mortality (8) 8
cell biology (8) 8
docetaxel (8) 8
efficacy (8) 8
kaplan-meier estimate (8) 8
postmenopausal women (8) 8
prognosis (8) 8
safety (8) 8
survival analysis (8) 8
tumors (8) 8
antineoplastic combined chemotherapy protocols - adverse effects (7) 7
cancer research (7) 7
clinical trials (7) 7
medicine & public health (7) 7
metastases (7) 7
multivariate analysis (7) 7
neoplasm staging (7) 7
paclitaxel (7) 7
research (7) 7
studies (7) 7
trial (7) 7
anastrozole (6) 6
antineoplastic agents - therapeutic use (6) 6
chemotherapy, adjuvant (6) 6
epidermal growth factor (6) 6
erbb-2 protein (6) 6
her2 (6) 6
lung neoplasms - drug therapy (6) 6
multicenter (6) 6
open-label (6) 6
patient outcomes (6) 6
receptor, erbb-2 - metabolism (6) 6
surgery (6) 6
antineoplastic agents - adverse effects (5) 5
bevacizumab (5) 5
breast neoplasms - chemistry (5) 5
breast neoplasms - metabolism (5) 5
carcinoma, non-small-cell lung - drug therapy (5) 5
disease progression (5) 5
double-blind (5) 5
endocrine therapy (5) 5
gene expression (5) 5
genes (5) 5
hematology (5) 5
mutation (5) 5
pathological complete response (5) 5
pertuzumab (5) 5
pharmacology & pharmacy (5) 5
physiology (5) 5
proportional hazards models (5) 5
research paper (5) 5
risk factors (5) 5
taxane (5) 5
time factors (5) 5
women (5) 5
anthracyclines (4) 4
antineoplastic agents - administration & dosage (4) 4
body mass index (4) 4
carboplatin (4) 4
carcinoma, non-small-cell lung - pathology (4) 4
cisplatin (4) 4
clinical medicine (4) 4
cohort studies (4) 4
erlotinib hydrochloride (4) 4
expression (4) 4
follow-up studies (4) 4
fulvestrant (4) 4
gemcitabine (4) 4
internal medicine (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 05/2017, Volume 35, Issue 14, pp. 1627 - 1627
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 10, pp. 981 - 988
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2015, Volume 5, Issue 1, p. 18670
Journal Article
Journal Article
Journal of Cancer Research and Clinical Oncology, ISSN 0171-5216, 04/2019, Volume 145, Issue 4, pp. 821 - 828
PurposeHormone receptors (HR) status in HER2+breast cancer (BC) is a recognized stratification factor with relevant clinical implication. According to HR... 
Molecular pathways | HER2 positive | PI3K | MAPK | Trastuzumab | MULTICENTER | EVEROLIMUS | OPEN-LABEL | PHASE-3 | COMBINATION | PERTUZUMAB | CROSS-TALK | LAPATINIB | ONCOLOGY | DOUBLE-BLIND | Genetic research | Anopheles | Breast cancer | Hormones | Analysis | Genes
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 2/2012, Volume 69, Issue 2, pp. 369 - 375
The aim of this study was to determine the activity and toxicity of two sequential chemotherapy regimens in the first-line treatment of advanced non-small-cell... 
First-line chemotherapy | Medicine & Public Health | Gemcitabine | Docetaxel | Non-small-cell lung cancer | Cancer Research | Oncology | Pharmacology/Toxicology | Cisplatin | Sequential chemotherapy | 1ST-LINE TREATMENT | PLUS CISPLATIN | CARBOPLATIN | MULTICENTER | METAANALYSIS | VINORELBINE | PACLITAXEL | ONCOLOGY | CLINICAL-TRIALS | COMBINATION CHEMOTHERAPY | PHARMACOLOGY & PHARMACY | DURATION | Lung Neoplasms - drug therapy | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Male | Fatigue - chemically induced | Cisplatin - administration & dosage | Leukopenia - chemically induced | Adult | Deoxycytidine - adverse effects | Female | Neutropenia - chemically induced | Taxoids - adverse effects | Carcinoma, Non-Small-Cell Lung - pathology | Drug Administration Schedule | Deoxycytidine - administration & dosage | Kaplan-Meier Estimate | Treatment Outcome | Taxoids - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cisplatin - adverse effects | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Neoplasm Staging | Deoxycytidine - analogs & derivatives | Care and treatment | Oncology, Experimental | Clinical trials | Research | Lung cancer, Non-small cell | Antineoplastic agents | Antimitotic agents | Complications and side effects | Cancer patients | Chemotherapy | Product development | Tumors | Cancer | Index Medicus
Journal Article
Breast Cancer: Targets and Therapy, ISSN 1179-1314, 03/2018, Volume 10, pp. 39 - 49
Journal Article
Molecular Plant Pathology, ISSN 1464-6722, 08/2015, Volume 16, Issue 6, p. 583
  Summary The xylanase inhibitor TAXI-III has been proven to delay Fusarium head blight (FHB) symptoms caused by Fusarium graminearum in transgenic durum wheat... 
Genetically modified plants | Genetic engineering | Hydrogen peroxide | Wheat | Analysis | Crop diseases | Transgenic plants | Genes | Apoptosis
Journal Article
Journal of Cellular Physiology, ISSN 0021-9541, 03/2018, Volume 233, Issue 3, pp. 2313 - 2323
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 10/2014, Volume 147, Issue 3, pp. 599 - 607
Journal Article
Journal of Cellular Physiology, ISSN 0021-9541, 06/2017, Volume 232, Issue 6, pp. 1571 - 1578
Journal Article
Journal of Cellular Physiology, ISSN 0021-9541, 06/2019, Volume 234, Issue 6, pp. 7708 - 7717
Journal Article
BioMed Research International, ISSN 2314-6133, 2018, Volume 2018, pp. 3756981 - 8
Journal Article